...
首页> 外文期刊>European journal of pediatrics >Functional residual capacity and compliance of the respiratory system after surfactant treatment in premature infants with severe respiratory distress syndrome.
【24h】

Functional residual capacity and compliance of the respiratory system after surfactant treatment in premature infants with severe respiratory distress syndrome.

机译:表面活性剂治疗后患有严重呼吸窘迫综合征的早产儿的功能残余容量和呼吸系统顺应性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

To understand the mechanisms behind improved oxygenation after intratracheal surfactant instillation, the immediate and late effects on lung volume and compliance of the respiratory system (CRS) were analysed. Infants received modified porcine surfactant (Curosurf) or modified bovine surfactant (Alveofact). Measurements of functional residual capacity (FRC) and CRS were successfully performed in 90 ventilated preterm infants (birth weight 1264+/-435 g; gestational age 28.2+/-2.5 weeks) with severe respiratory distress syndrome. FRC and CRS were measured during mechanical ventilation prior to and 1, 3, 6, 24, 48, 72, 96, 120 and 168 h after surfactant replacement. Oxygenation rapidly improved. FRC increased significantly from 7.64+/-1.58 ml/kg to 15.35+/-3.27 ml/kg ( P<0.01) at 1 h after surfactant instillation. CRS remained virtually unchanged during the first hours after surfactant replacement and a concomitant decrease in specific compliance was seen. CONCLUSION: the changes in lung function following surfactant treatment can only be explained by initial stabilisation of already aerated alveoli followed by recruitment of new gas exchange units as mechanisms involved in mediating the effect of surfactant on gas exchange. However, since no significant correlation between changes in functional residual capacity and improvement in arterial-to-alveolar oxygen tension ratio was seen, other effects of surfactant must be considered. These include local and/or systemic changes in haemodynamics.
机译:为了了解气管内表面活性剂滴注后改善氧合作用的机制,分析了对肺活量和呼吸系统顺应性(CRS)的即时和晚期影响。婴儿接受了改良的猪表面活性剂(Curosurf)或改良的牛表面活性剂(Alveofact)。在患有严重呼吸窘迫综合征的90名通气早产儿(出生体重1264 +/- 435 g;胎龄28.2 +/- 2.5周)中成功进行了功能残留能力(FRC)和CRS的测量。在更换表面活性剂之前,1、3、6、24、48、72、96、120和168小时之前的机械通气期间测量FRC和CRS。氧合迅速改善。滴注表面活性剂后1小时,FRC从7.64 +/- 1.58 ml / kg显着增加到15.35 +/- 3.27 ml / kg(P <0.01)。在更换表面活性剂后的最初几个小时中,CRS几乎保持不变,并且比顺应性随之下降。结论:表面活性剂治疗后肺功能的改变只能通过已经充气的肺泡的初步稳定,然后募集新的气体交换单元作为介导表面活性剂对气体交换作用的机制来解释。但是,由于在功能残余容量的变化与动脉与肺泡氧张力比的改善之间未发现显着相关性,因此必须考虑表面活性剂的其他作用。这些包括血液动力学的局部和/或全身变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号